Dr. Saby George, MD

Dr. George practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. George's NPI, 1063686418, was assigned on April 16, 2008. Dr. George graduated from Kottayam Medical College in 1999. Dr. George holds New York license 257160.

Dr. George's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. George's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. George is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center. Dmand AI also links Dr. George to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. George practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. George's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. George is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. George's licenses on file in 2 states: New York and Ohio.

Dmand AI lists prostate cancer among the conditions Dr. George treats.

CMS data shows 152 Medicare services from Dr. George across 2 procedure codes in 2024, all of them office visits, for 93 Medicare patients. Medicare paid $17,155 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. George in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. George's median patient age at 73, with 17% women.

In 2024, Dr. George wrote 31 Medicare Part D claims for 13 patients. 52% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $60 in total drug cost. In 2016, CMS named 33 claims across 2 drugs.

Dr. George accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 83 papers to Dr. George, published from 2007 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. George has published most often in Clin Genitourin Cancer. Dr. George's most frequent co-authors are Toni K. Choueiri, MD, Robert J. Motzer, MD and Hans Joerg Hammers, MD, PhD.

Dmand AI links Dr. George to 12 clinical trials, 4 of them phase 1/2 studies. 4 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Kidney Neoplasms and Prostatic Neoplasms. Roswell Park Cancer Institute sponsors the most, 7. Open Payments lists research payments to Dr. George that name 1 trial.

CMS Open Payments shows 356 general payments to Dr. George from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Bristol-Myers Squibb Company paid the most, $90,587. It also lists 11 research payments totaling $22,488 from 2017 to 2025, naming 1 clinical trial.

Dr. George graduated from Kottayam Medical College in 1999.

Dr. George is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.